Athersys, Inc. and Center for Stem Cell and Regenerative Medicine Receive Grant Funding to Support Research Into Novel Stem Cell Treatment of Spinal Cord Injury

CLEVELAND, June 25, 2010 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) and its collaborators, including the Center for Stem Cell and Regenerative Medicine (CSCRM) and Case Western Reserve University (CWRU), announced today that they have been awarded $1 million through the Ohio Third Frontier Biomedical Program to support research into the treatment of spinal cord injury (SCI) with MultiStem®, Athersys' proprietary stem cell product candidate. The project is intended to advance preclinical and translational research involving the use of MultiStem as a treatment for damage associated with SCI.